Cooperative Agreement NU50CK000576

Federal Cooperative Agreement Summary The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) awarded the Association of Public Health Laboratories, Inc. (APHL) a $6.98 million Cooperative Agreement under the Emerging Infections Programs (EIP, CFDA 93.317) to enhance public health laboratory capabilities and capacities from July 1, 2025, through June 30, 2030. This five-year award supports APHL's mission to strengthen laboratory infrastructure, surveillance systems, and...

Federal Project Grant Award Summary The American Society of Health-System Pharmacists Inc. (ASHP) received a $3.0 million Project Grant from the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research under the FDA Research program (CFDA 93.103) for the period September 25, 2025, through August 31, 2028. The award funds a comprehensive initiative to identify drugs vulnerable to shortage or fraudulent activity and to address barriers to outsourcing facility production of...

This Project Grant award from the National Science Foundation provides $999,610 to The University of New Mexico to establish the Center for Emerging Pathogen Prediction and Integration (CEPPI) from September 1, 2022 through February 29, 2024. CEPPI will develop predictive models and workflows to strengthen global pathogen surveillance and pandemic prevention under the Biological Sciences (CFDA 47.074) program. Key products include establishing informatics baselines on pathogens and hosts from...

Federal Grant Award Summary Duke University received a $962,973 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 – Allergy and Infectious Diseases Research) awarded August 12, 2025, with completion targeted for July 31, 2030. The Pharmacists for Prevention (P4P) initiative will develop and implement a comprehensive HIV prevention curriculum across six pharmacy schools located in the Southern United States, specifically in Ending the HIV Epidemic (EHE)...

Summary Empowerx, Inc., a woman-owned small business, received a $485,654 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) on September 22, 2025, with a completion date of August 31, 2026. The award funds the PEP/PREP Via Pharmacist-Prescribing Implementation (PEPPI) project, which will develop user-informed software to support the implementation of pharmacist-prescribed post-exposure prophylaxis (PEP) and...

PHARMA-GIRL Project Grant Summary The University of California, San Francisco received a $408,643 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) for the period February 1, 2026 through January 31, 2028. The PHARMA-GIRL project conducts implementation science research to evaluate pharmacy-based HIV prevention and treatment service delivery models targeting adolescent...

Federal Project Grant Award Summary The University of Alabama at Birmingham received a $453,804 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 3, 2025, through August 31, 2027. This award supports the "Pharmacy-Centered Rapid ARV Network: Capacity-Building for Status-Neutral ART/PrEP Services Within Southern Community Pharmacies" initiative, which...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

Federal Project Grant Award Summary Emory University received a $797,734 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 9, 2025, through May 31, 2030. This research project investigates the effects of doxycycline post-exposure prophylaxis (doxy-PEP) on inflammation and the microbiome among men who have sex with men (MSM) and transgender women (TGW), both with and...

Federal Grant Award Summary: HIP-PHARM Project Wake Forest University Health Sciences received a $1.55 million Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2025, through March 31, 2030. The HIP-PHARM (Integrated HIV and Overdose Prevention in Pharmacies) project delivers a comprehensive research assessment of HIV pre-exposure prophylaxis (PrEP) and overdose prevention service...